CHC
ABBV icon

City Holding Co’s AbbVie ABBV Stock Holding History

City Holding Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Sell
43,975
-1,322
-3% -$284K 1.25% 15
2026
Q1 		$9.85M Buy
45,297
+156
+0.3% +$34.6K 1.23% 17
2025
Q4 		$10.3M Buy
45,141
+1,887
+4% +$430K 1.27% 14
2025
Q3 		$10M Buy
43,254
+758
+2% +$154K 1.26% 14
2025
Q2 		$7.89M Buy
42,496
+1,666
+4% +$310K 1.03% 22
2025
Q1 		$8.55M Buy
40,830
+733
+2% +$142K 1.21% 19
2024
Q4 		$7.13M Sell
40,097
-510
-1% -$93.8K 1.01% 23
2024
Q3 		$8.02M Buy
40,607
+125
+0.3% +$23.3K 1.11% 20
2024
Q2 		$6.94M Buy
40,482
+148
+0.4% +$24.5K 1.03% 22
2024
Q1 		$7.34M Buy
40,334
+438
+1% +$75.5K 1.1% 22
2023
Q4 		$6.18M Buy
39,896
+372
+0.9% +$54.2K 1% 24
2023
Q3 		$5.89M Buy
39,524
+3,107
+9% +$456K 1.05% 24
2023
Q2 		$4.91M Buy
36,417
+2,161
+6% +$317K 0.84% 30
2023
Q1 		$5.46M Buy
34,256
+1,969
+6% +$301K 0.98% 26
2022
Q4 		$5.22M Buy
32,287
+1,925
+6% +$295K 0.97% 26
2022
Q3 		$4.08M Buy
30,362
+2,492
+9% +$358K 0.81% 35
2022
Q2 		$4.27M Buy
27,870
+1,846
+7% +$282K 0.8% 36
2022
Q1 		$4.22M Sell
26,024
-360
-1% -$52.3K 0.68% 42
2021
Q4 		$3.9M Sell
26,384
-2,918
-10% -$345K 0.65% 42
2021
Q3 		$3.16M Buy
29,302
+1,504
+5% +$172K 0.54% 55
2021
Q2 		$3.13M Buy
27,798
+2,313
+9% +$260K 0.55% 54
2021
Q1 		$2.76M Buy
25,485
+360
+1% +$38.5K 0.53% 58
2020
Q4 		$2.69M Buy
25,125
+1,580
+7% +$152K 0.56% 56
2020
Q3 		$2.06M Buy
23,545
+225
+1% +$21.2K 0.47% 76
2020
Q2 		$2.29M Buy
23,320
+3,234
+16% +$285K 0.57% 59
2020
Q1 		$1.53M Buy
20,086
+1,100
+6% +$93.7K 0.46% 79
2019
Q4 		$1.68M Buy
18,986
+465
+3% +$38.6K 0.4% 82
2019
Q3 		$1.4M Buy
18,521
+330
+2% +$22.6K 0.36% 91
2019
Q2 		$1.32M Sell
18,191
-15,228
-46% -$1.2M 0.36% 96
2019
Q1 		$2.69M Sell
33,419
-548
-2% -$44.8K 0.76% 46
2018
Q4 		$3.13M Sell
33,967
-235
-0.7% -$20.7K 1.02% 27
2018
Q3 		$3.23M Sell
34,202
-1,330
-4% -$126K 0.93% 33
2018
Q2 		$3.29M Buy
35,532
+458
+1% +$44.7K 1.01% 25
2018
Q1 		$3.32M Sell
35,074
-445
-1% -$48.9K 1.06% 20
2017
Q4 		$3.44M Sell
35,519
-6,467
-15% -$609K 1.09% 20
2017
Q3 		$3.73M Sell
41,986
-213
-0.5% -$16.2K 1.25% 13
2017
Q2 		$3.06M Sell
42,199
-330
-0.8% -$22.2K 1.08% 19
2017
Q1 		$2.77M Buy
42,529
+819
+2% +$51.5K 1.04% 19
2016
Q4 		$2.61M Buy
41,710
+1,663
+4% +$102K 1.02% 21
2016
Q3 		$2.52M Buy
40,047
+573
+1% +$37.1K 1.09% 17
2016
Q2 		$2.44M Buy
39,474
+2,672
+7% +$163K 1.09% 20
2016
Q1 		$2.1M Buy
36,802
+1,900
+5% +$106K 1.05% 22
2015
Q4 		$2.07M Buy
34,902
+747
+2% +$43K 1.07% 22
2015
Q3 		$1.86M Sell
34,155
-1,350
-4% -$87.9K 1.01% 23
2015
Q2 		$2.39M Sell
35,505
-373
-1% -$24.4K 1.21% 15
2015
Q1 		$2.1M Buy
35,878
+3,468
+11% +$210K 1.07% 23
2014
Q4 		$2.12M Buy
32,410
+620
+2% +$39.1K 1.11% 19
2014
Q3 		$1.84M Buy
31,790
+3,020
+10% +$168K 1.02% 25
2014
Q2 		$1.51M Buy
28,770
+964
+3% +$50.6K 0.87% 32
2014
Q1 		$1.43M Sell
27,806
-275
-1% -$13.9K 0.87% 34
2013
Q4 		$1.48M Buy
+28,081
New +$1.38M 0.93% 30

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

City Holding Co's ABBV Position: Q2 2026 in Review

City Holding Co reduced its AbbVie (ABBV) stake by 2.9% in Q2 2026, selling an estimated $284K and leaving 43,975 shares worth $11.1M. The position accounts for 1.25% of the portfolio, ranked #15.

City Holding Co first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 957 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • City Holding Co held 43,975 shares of AbbVie worth $11.1M as of Q2 2026.
  • City Holding Co sold 1,322 AbbVie shares in Q2 2026, an estimated $284K.
  • AbbVie made up 1.25% of City Holding Co's portfolio in Q2 2026, its #15 holding.
  • City Holding Co first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • 957 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.